mephenytoin
E1559896
UNEXPLORED
Mephenytoin is an anticonvulsant drug historically used to treat epilepsy and known for its role as a probe substrate in pharmacogenetic studies of CYP2C19 enzyme activity.
All labels observed (1)
| Label | Occurrences |
|---|---|
| mephenytoin canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T22889013 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: mephenytoin Context triple: [CYP2C19, metabolizes, mephenytoin]
-
A.
phenytoin
Phenytoin is an antiepileptic medication commonly used to prevent and control seizures by stabilizing neuronal activity in the brain.
-
B.
carbamazepine
Carbamazepine is an anticonvulsant and mood-stabilizing drug commonly used to treat epilepsy, trigeminal neuralgia, and bipolar disorder.
-
C.
valproate
Valproate is an anticonvulsant and mood-stabilizing medication widely used to treat epilepsy, bipolar disorder, and to prevent migraine headaches.
-
D.
lamotrigine
Lamotrigine is an anticonvulsant medication primarily used to treat epilepsy and bipolar disorder by stabilizing neuronal activity and reducing the frequency of seizures or mood episodes.
-
E.
vigabatrin
Vigabatrin is an antiepileptic medication that irreversibly inhibits GABA transaminase to increase brain GABA levels, used mainly for refractory seizures such as infantile spasms but associated with risks like permanent visual field loss.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: mephenytoin Target entity description: Mephenytoin is an anticonvulsant drug historically used to treat epilepsy and known for its role as a probe substrate in pharmacogenetic studies of CYP2C19 enzyme activity.
-
A.
phenytoin
Phenytoin is an antiepileptic medication commonly used to prevent and control seizures by stabilizing neuronal activity in the brain.
-
B.
carbamazepine
Carbamazepine is an anticonvulsant and mood-stabilizing drug commonly used to treat epilepsy, trigeminal neuralgia, and bipolar disorder.
-
C.
valproate
Valproate is an anticonvulsant and mood-stabilizing medication widely used to treat epilepsy, bipolar disorder, and to prevent migraine headaches.
-
D.
lamotrigine
Lamotrigine is an anticonvulsant medication primarily used to treat epilepsy and bipolar disorder by stabilizing neuronal activity and reducing the frequency of seizures or mood episodes.
-
E.
vigabatrin
Vigabatrin is an antiepileptic medication that irreversibly inhibits GABA transaminase to increase brain GABA levels, used mainly for refractory seizures such as infantile spasms but associated with risks like permanent visual field loss.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.